1. Home
  2. UHT vs FLGT Comparison

UHT vs FLGT Comparison

Compare UHT & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UHT

Universal Health Realty Income Trust

HOLD

Current Price

$42.29

Market Cap

562.9M

Sector

Real Estate

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$27.12

Market Cap

697.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHT
FLGT
Founded
1986
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
562.9M
697.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
UHT
FLGT
Price
$42.29
$27.12
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$28.33
AVG Volume (30 Days)
105.3K
265.4K
Earning Date
10-27-2025
11-07-2025
Dividend Yield
6.97%
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$100,898,000.00
$315,549,000.00
Revenue This Year
$0.71
$16.84
Revenue Next Year
$2.00
$9.74
P/E Ratio
$32.49
N/A
Revenue Growth
1.00
13.61
52 Week Low
$34.56
$14.57
52 Week High
$43.00
$31.04

Technical Indicators

Market Signals
Indicator
UHT
FLGT
Relative Strength Index (RSI) 68.57 47.00
Support Level $39.44 $26.69
Resistance Level $41.19 $31.04
Average True Range (ATR) 0.88 0.77
MACD 0.13 -0.46
Stochastic Oscillator 81.04 10.80

Price Performance

Historical Comparison
UHT
FLGT

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: